“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Text size:

CDC Advisory Committee Flip Flops on FluMist


“I’m a little concerned about whether it would be interpreted that we’re compromising our interpretation of the science.” — Henry Bernstein, MD

On June, 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended against using the live nasal spray version of the influenza vaccine known as FluMist during the 2016-2017 influenza season.

After reviewing data for 2013-2016, ACIP determined that the “FluMist Quadrivalent” live attenuated influenza vaccine (LAIV), was only three percent effective in protecting children two to seven years of age against influenza. The three percent figure is so low that, for all practical purposes, the vaccine provided no protection, or at least that “no protective benefit could be measured.”1 Last year, the ACIP again recommended against using the FluMist Quadrivalent vaccine.2 

The decisions by the ACIP during the past two years have now been reversed. On February 21, 2018, the ACIP voted 12-2 to add FluMist Quadrivalent to the CDC’s list of recommended vaccines for the 2018-2019 influenza season.3 According to an article in STAT magazine, there had been “mounting concern” that MedImmune, the maker of FluMist, would “abandon the vaccine if it could not find a way back to the U.S. market.”3

The latest decision by the ACIP fell short of a resounding endorsement of FluMist Quadrivalent. The Committee left it up to doctors to decide whether or not do administer it. It stated:

For the 2018-19 season, immunization providers may choose to administer any licensed, age appropriate, influenza vaccine (including LAIV, IIV and RIV). LAIV4 is an option for influenza vaccination for persons for whom it is otherwise appropriate.4 5

LAIV4 (Live Attenuated Influenza Vaccine 4) refers to FluMist Quadrivalent.6

Some members of of the ACIP expressed concern about the new recommendation because they felt it would “confuse both the public and health care providers who administer flu vaccines.”3 ACIP member Henry Bernstein, MD of the Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY said, “I’m a little concerned about whether it would be interpreted that we’re compromising our interpretation of the science.” Dr. Bernstein voted against the recommendation.3


1 U.S. Centers for Disease Control and Prevention. ACIP votes down use of LAIV for 2016-2017 flu season. CDC.gov
2 Scutti S. CDC panel again advises against FluMist. CNN June 21, 2017.
3 Branswell H. FluMist is back: Vote reopens the way to wider use of popular vaccine. STAT Feb. 21, 2018.
4 Fox M. FluMist nasal flu vaccine can come back, vaccine advisers say. NBC News Feb. 22, 2018.
5 Leonard K. Nasal flu vaccine to make a comeback. Washington Examiner Feb. 25, 2018.
6 Brown T. Nasal Flu Vaccine Back on CDC List of Recommended Vaccines. Medscape Feb. 22, 2018.

9 Responses to CDC Advisory Committee Flip Flops on FluMist

  1. Nicholas Kottenstette Reply

    March 7, 2018 at 4:53 pm

    I’m not sure what the original post met – typo?? (sorry I didn’t realize you were commenting to above post).

  2. Debra A Gregory Reply

    March 3, 2018 at 7:59 pm

    The manufacturer threatened to bail? Hmmm … history repeating itself. As I recall that’s how we got in this mess (vaccines that don’t work, aren’t gold standard tested, harm or both) to begin with! They should have been allowed to take the ball and not only go home, but stay home.

  3. William Schmittmeyer Reply

    February 28, 2018 at 1:02 pm

    Flumist is a live vaccine as is whooping cough and shingles and the MMR.Any live vaccine sheds for up to 2 months in the saliva and feces infecting everyone you come into contact with.Will you ever hear that on the pharma controlled media.Not in the USA or New Zealand where Pharma ads are allowed on tv.

  4. Linda Abernethy Reply

    February 28, 2018 at 7:51 am

    What is up with your reCaptcha, it is truly confounding.

  5. Linda Abernethy Reply

    February 28, 2018 at 7:46 am

    Del Bigtree who made the movie,Vaxxed, has a Utube channel called High-wire or the High-wire. He is doing a wonderful job up there on the high wire-above all the clowns who are attempting to distract “we the people”. Consider subscribing to his channel.

  6. Colorado Reply

    February 27, 2018 at 10:15 pm

    There is possibly more nagalase than cure. Qued up, now it’s your turn to bat. Game on.

    • Linda Abernethy Reply

      February 28, 2018 at 7:47 am

      What does this mean?

      • Nicholas Kottenstette Reply

        March 4, 2018 at 2:00 pm

        Buisness as usual. Hypocrisy has no bounds. The vaccine injury act was passed under similar pressure. Manufacturers couldn’t make a safe and effective DTP vaccine so they threatened to stop making DTP & Congress responded in kind by saying you don’t need to make vaccines safe, just keep making them.

      • Colorado Reply

        March 6, 2018 at 1:26 pm

        New hypotheses floating on the net. The case of the many mysteriously disappearing doctors. Reportedly looking into GcMAF, and the relationship to nagalase in vaccines. Don’t forget to watch your free Injecting Aluminum doc, only 2 days left. http://cinemalibrestudio.com/injecting-aluminum/IAevent.html But even if you have to pay, it’s a worthwhile watch. Proven measurable science regarding muscle reaction to aluminum.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>